Formic acid dissolves aggregates of an N-terminal huntingtin fragment containing an expanded polyglutamine tract: Applying to quantification of protein components of the aggregates

被引:80
作者
Hazeki, N [1 ]
Tukamoto, T
Goto, J
Kanazawa, I
机构
[1] Japan Sci & Technol Corp, CREST, Tokyo, Japan
[2] Univ Tokyo, Grad Sch Med, Dept Neurol, Div Neurosci,Bunkyo Ku, Tokyo 1138655, Japan
关键词
formic acid; Huntington's disease; proteasome; aggregate;
D O I
10.1006/bbrc.2000.3682
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Huntington's disease (HD) is caused by an expansion of the CAG repeat that encodes polyglutamine in huntingtin, Transient expression of an N-terminal huntingtin fragment containing an expanded polyglutamine tract induced formation of protein aggregates in cultured cells. The turnover of protein components in such aggregates has been difficult to study because of their insolubility in aqueous solutions. Here we describe a method of solubilizing the aggregates and quantifying their protein components. Insoluble pellets were collected from COS7 cells expressing an N-terminal huntingtin fragment containing an expanded polyglutamine tract and subjected to treatment with various detergent, acid, and alkaline reagents. Treatment with 100% formic acid at 37 degreesC for 30 min induced essentially complete dissociation of the aggregates to monomer, We used this solubilization technique to quantify huntingtin fusion protein in the aggregates formed in transient expression experiments. The frequency of aggregate formation increased when the proteasome inhibitor beta -lactone was added to culture media. However, the total amount of accumulated huntingtin fusion protein did not differ between cells cultured with or without beta -lactone, These results suggest that other protein components which are degraded by the proteasome, in addition to huntingtin, might be related to the dynamics of polyglutamine protein aggregates. (C) 2000 Academic Press.
引用
收藏
页码:386 / 393
页数:8
相关论文
共 29 条
[1]   Evidence for proteasome involvement in polyglutamine disease:: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro [J].
Chai, YH ;
Koppenhafer, SL ;
Shoesmith, SJ ;
Perez, MK ;
Paulson, HL .
HUMAN MOLECULAR GENETICS, 1999, 8 (04) :673-682
[2]   THE UBIQUITIN-PROTEASOME PROTEOLYTIC PATHWAY [J].
CIECHANOVER, A .
CELL, 1994, 79 (01) :13-21
[3]  
CRISTOFARO T, 1999, BIOCHEM BIOPH RES CO, V260, P150
[4]   Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1 [J].
Cummings, CJ ;
Mancini, MA ;
Antalffy, B ;
DeFranco, DB ;
Orr, HT ;
Zoghbi, HY .
NATURE GENETICS, 1998, 19 (02) :148-154
[5]   Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation [J].
Davies, SW ;
Turmaine, M ;
Cozens, BA ;
DiFiglia, M ;
Sharp, AH ;
Ross, CA ;
Scherzinger, E ;
Wanker, EE ;
Mangiarini, L ;
Bates, GP .
CELL, 1997, 90 (03) :537-548
[6]   Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain [J].
DiFiglia, M ;
Sapp, E ;
Chase, KO ;
Davies, SW ;
Bates, GP ;
Vonsattel, JP ;
Aronin, N .
SCIENCE, 1997, 277 (5334) :1990-1993
[7]   INHIBITION OF PROTEASOME ACTIVITIES AND SUBUNIT-SPECIFIC AMINO-TERMINAL THREONINE MODIFICATION BY LACTACYSTIN [J].
FENTEANY, G ;
STANDAERT, RF ;
LANE, WS ;
CHOI, S ;
COREY, EJ ;
SCHREIBER, SL .
SCIENCE, 1995, 268 (5211) :726-731
[8]   Rapid aggregate formation of the huntingtin N-terminal fragment carrying an expanded polyglutamine tract [J].
Hazeki, N ;
Nakamura, K ;
Goto, J ;
Kanazawa, I .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 256 (02) :361-366
[9]   Spinocerebellar ataxia type 7 (SCA7):: a neurodegenerative disorder with neuronal intranuclear inclusions [J].
Holmberg, M ;
Duyckaerts, C ;
Dürr, A ;
Cancel, G ;
Gourfinkel-An, I ;
Damier, P ;
Faucheux, B ;
Trottier, Y ;
Hirsch, EC ;
Agid, Y ;
Brice, A .
HUMAN MOLECULAR GENETICS, 1998, 7 (05) :913-918
[10]   Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch [J].
Igarashi, S ;
Koide, R ;
Shimohata, T ;
Yamada, M ;
Hayashi, Y ;
Takano, H ;
Date, H ;
Oyake, M ;
Sato, T ;
Sato, A ;
Egawa, S ;
Ikeuchi, T ;
Tanaka, H ;
Nakano, R ;
Tanaka, K ;
Hozumi, I ;
Inuzuka, T ;
Takahashi, H ;
Tsuji, S .
NATURE GENETICS, 1998, 18 (02) :111-117